tradingkey.logo

Haleon PLC

HLN
9.881USD
+0.311+3.25%
Horário de mercado ETCotações atrasadas em 15 min
88.78BValor de mercado
61.57P/L TTM

Mais detalhes de Haleon PLC Empresa

Haleon plc is a consumer healthcare company. The Company's product portfolio includes five categories, including oral health, vitamins, minerals, and supplements (VMS), pain relief, respiratory health, digestive health and others. The Company’s geographical segments include North America, Europe, Middle East, Africa, and Latin America (EMEA and LatAm, and Asia Pacific (APAC). Its respiratory health brands offer product solutions for a range of respiratory issues, including cold and flu, nasal congestion, coughs, and allergies. The Company's digestive health and other product offerings also include skin health and smoker’s health. Its oral health brands include Sensodyne, Polident, Parodontax, and Biotene. Its VMS brands include Centrum, Emergen-C, and Caltrate. Its respiratory brands include Otrivin, Theraflu, and Flonase. Its pain relief brands include Voltaren, Panadol, and Advil. Its digestive health brands include TUMS, ENO, and Fenistil.

Informações de Haleon PLC

Código da empresaHLN
Nome da EmpresaHaleon PLC
Data de listagemJul 18, 2022
CEOMr. Brian Mcnamara
Número de funcionários- -
Tipo de títulosOrdinary Share
Fim do ano fiscalJul 18
EndereçoBuilding 5, First Floor
CidadeWEYBRIDGE
Bolsa de valoresLondon Stock Exchange
PaísUnited Kingdom
Código postalKT13 0NY
Telefone441932822000
Sitehttps://www.haleon.com/
Código da empresaHLN
Data de listagemJul 18, 2022
CEOMr. Brian Mcnamara

Executivos da empresa Haleon PLC

Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
446.70K
+0.46%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Ed Petter
Mr. Ed Petter
Chief Corporate Affairs Officer
Chief Corporate Affairs Officer
--
--
Ms. Tracy Clarke
Ms. Tracy Clarke
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Sir Dave Lewis
Sir Dave Lewis
Independent Non-Executive Chairman of the Board
Independent Non-Executive Chairman of the Board
--
--
Mr. Keith Choy
Mr. Keith Choy
President, Asia Pacific
President, Asia Pacific
--
--
Ver Mais
Nome
Nome/Posição
Posição
Ações detidas
Variação
Mr. Brian Mcnamara
Mr. Brian Mcnamara
Chief Executive Officer, Executive Director
Chief Executive Officer, Executive Director
446.70K
+0.46%
Ms. Lisa Paley
Ms. Lisa Paley
President, North America
President, North America
174.31K
+774.13%
Mr. Matt Shattock
Mr. Matt Shattock
Non-Executive Independent Director
Non-Executive Independent Director
--
--
Mr. Jo Russell
Mr. Jo Russell
Head of Investor Relations
Head of Investor Relations
--
--
Mr. Adrian Morris
Mr. Adrian Morris
General Counsel
General Counsel
--
--
Ms. Blathnaid Bergin
Ms. Blathnaid Bergin
Non-Executive Independent Director
Non-Executive Independent Director
--
--

Detalhamento da receita

Moeda: USDAtualizado em: seg, 6 de out
Moeda: USDAtualizado em: seg, 6 de out
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
Por EmpresaUSD
Nome
Receita
Proporção
Oral health
848.00M
32.28%
Pain relief
625.00M
23.79%
Respiratory health
428.00M
16.29%
Vitamins, minerals and supplements
417.00M
15.87%
Therapeutic Skin Health and Other
249.00M
9.48%
Digestive health and other
60.00M
2.28%
Por RegiãoUSD
Nome
Receita
Proporção
EMEA and LatAm
1.12B
42.67%
Northern America
871.00M
33.16%
APAC
635.00M
24.17%
Por Empresa
Por Região
Por EmpresaUSD
Nome
Receita
Proporção
Oral health
848.00M
32.28%
Pain relief
625.00M
23.79%
Respiratory health
428.00M
16.29%
Vitamins, minerals and supplements
417.00M
15.87%
Therapeutic Skin Health and Other
249.00M
9.48%
Digestive health and other
60.00M
2.28%

Distribuição de ações

Atualizado em: sáb, 16 de ago
Atualizado em: sáb, 16 de ago
Investidores
Tipos de investidores
Investidores
Investidores
Proporção
Dodge & Cox
3.49%
Fidelity Management & Research Company LLC
2.19%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.51%
Fidelity Institutional Asset Management
0.32%
Outro
92.79%
Investidores
Investidores
Proporção
Dodge & Cox
3.49%
Fidelity Management & Research Company LLC
2.19%
ClearBridge Investments, LLC
0.71%
Harding Loevner LP
0.51%
Fidelity Institutional Asset Management
0.32%
Outro
92.79%
Tipos de investidores
Investidores
Proporção
Investment Advisor/Hedge Fund
5.74%
Investment Advisor
5.41%
Hedge Fund
0.78%
Research Firm
0.73%
Bank and Trust
0.17%
Family Office
0.07%
Family Office
0.06%
Family Office
0.06%
Individual Investor
0.02%
Outro
86.97%

Participação acionária institucional

Atualizado em: qua, 1 de out
Atualizado em: qua, 1 de out
Período do relatório
N.º de instituições
Ações detidas
Proporção
Variação
2025Q3
1049
570.14M
12.80%
-16.29M
2025Q2
1049
577.49M
12.86%
-190.91M
2025Q1
1077
574.94M
12.79%
-194.57M
2024Q4
1094
745.67M
16.47%
-9.34M
2024Q3
1096
717.29M
15.74%
-81.04M
2024Q2
1078
719.27M
15.75%
-155.43M
2024Q1
1041
707.36M
15.49%
-53.58M
2023Q4
993
691.96M
14.98%
-58.05M
2023Q3
933
688.70M
14.92%
-37.88M
2023Q2
891
677.74M
14.68%
-44.11M
Ver Mais

Atividade dos acionistas

Nome
Ações detidas
Proporção
Variação
Var. %
Data
Dodge & Cox
155.47M
3.49%
-13.68M
-8.09%
Jun 30, 2025
Fidelity Management & Research Company LLC
97.52M
2.19%
+357.98K
+0.37%
Jun 30, 2025
ClearBridge Investments, LLC
31.45M
0.71%
-1.15M
-3.52%
Jun 30, 2025
Harding Loevner LP
22.55M
0.51%
-520.88K
-2.26%
Jun 30, 2025
Fidelity Institutional Asset Management
14.24M
0.32%
-53.53K
-0.37%
Jun 30, 2025
Wellington Management Company, LLP
13.09M
0.29%
-122.94K
-0.93%
Sep 23, 2025
Managed Account Advisors LLC
10.98M
0.25%
+6.14M
+127.05%
Jun 30, 2025
Sculptor Capital Management, Inc
9.95M
0.22%
-900.00K
-8.30%
Jun 30, 2025
Aristotle Capital Management, LLC
8.20M
0.18%
-241.03K
-2.86%
Jun 30, 2025
Parametric Portfolio Associates LLC
8.19M
0.18%
+521.39K
+6.80%
Jun 30, 2025
Ver Mais

ETFs Relacionados

Atualizado em: qui, 6 de nov
Atualizado em: qui, 6 de nov
Nome
Proporção
VanEck Pharmaceutical ETF
2.91%
Franklin ClearBridge Enhanced Income ETF
1.76%
One Global ETF
0.63%
ActivePassive International Equity ETF
0.33%
SP Funds S&P World (ex-US) ETF
0.25%
Avantis Responsible International Equity ETF
0.08%
Avantis International Equity ETF
0.08%
Avantis International Large Cap Value ETF
0%
Unusual Whales Subversive Democratic Trading ETF
0%
Fidelity Blue Chip Value ETF
0%
Ver Mais
VanEck Pharmaceutical ETF
Proporção2.91%
Franklin ClearBridge Enhanced Income ETF
Proporção1.76%
One Global ETF
Proporção0.63%
ActivePassive International Equity ETF
Proporção0.33%
SP Funds S&P World (ex-US) ETF
Proporção0.25%
Avantis Responsible International Equity ETF
Proporção0.08%
Avantis International Equity ETF
Proporção0.08%
Avantis International Large Cap Value ETF
Proporção0%
Unusual Whales Subversive Democratic Trading ETF
Proporção0%
Fidelity Blue Chip Value ETF
Proporção0%

Dividendo

Um total de 570.00M USD foi distribuído em dividendos nos últimos 5 anos.
Data
Dividendo
Data de registro
Data de pagamento
Data ex-dividendo
Aug 01, 2024
HLN.NB Final Cash Dividend of gross USD 0.051416 paid on Sep 19, 2024 going ex on Aug 16, 2024
Aug 16, 2024
Sep 19, 2024
Aug 16, 2024
Feb 29, 2024
HLN.NB Interim Cash Dividend of gross USD 0.105268 paid on May 16, 2024 going ex on Mar 14, 2024
Mar 15, 2024
May 16, 2024
Mar 14, 2024
Aug 02, 2023
HLN.NB Final Cash Dividend of gross USD 0.043871 paid on Oct 05, 2023 going ex on Aug 24, 2023
Aug 25, 2023
Oct 05, 2023
Aug 24, 2023
Mar 02, 2023
HLN.NB Interim Cash Dividend of gross USD 0.059732 paid on Apr 27, 2023 going ex on Mar 16, 2023
Mar 17, 2023
Apr 27, 2023
Mar 16, 2023

Desdobramento de ações

Data
Tipo
Proporção
Sem dados
Data
Tipo
Proporção
Sem dados
KeyAI